youtube_live
Q3 2026 earnings • released • EPS beat +२.३२% • Revenue miss -०.१६%
See resultschevron_right
ALC:NYSE
Alcon AG
US$ ७१.१८
arrow_downward
-४.१०%(-३.०४) 1D
नोभेम्बर ११, ०९:४३:१४ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
US$ ७१.७०
High
US$ ७२.३४
Low
US$ ७०.४६
Mkt. cap
२९.८३ अरब
Avg. vol.
१९.७६ लाख
Volume
३.३० लाख
52-wk high
US$ ८७.६४
52-wk low
US$ ६१.८४
Beta
०.८७
Shares outstanding
४८.३४ करोड
No. of employees
२५ हजार
Open
US$ ७१.७०
High
US$ ७२.३४
Low
US$ ७०.४६
Mkt. cap
२९.८३ अरब
Avg. vol.
१९.७६ लाख
Volume
३.३० लाख
52-wk high
US$ ८७.६४
52-wk low
US$ ६१.८४
Beta
०.८७
Shares outstanding
४८.३४ करोड
No. of employees
२५ हजार
News stories
From web sources and news partners
Investing.com Canada
·
९ मिनेट पहिले
Alcon Q3 2026 presentation: EPS beats forecast, shares fall on revenue
Benzinga
·
२६ मिनेट पहिले
Alcon Q3 2026 Earnings Call Transcript
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees२५ हजार
Founded१९४५
Headquartersजेनेभा, Geneva, स्विट्जरल्यान्ड
SectorHealth Care
Industry-
Websitealcon.com